首页> 美国卫生研究院文献>Molecular Endocrinology >Dexamethasone Induces a Putative Repressor Complex and Chromatin Modifications in the CRH Promoter
【2h】

Dexamethasone Induces a Putative Repressor Complex and Chromatin Modifications in the CRH Promoter

机译:地塞米松诱导CRH启动子推定的阻遏物复合物和染色质修饰。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glucocorticoids down-regulate expression of hypothalamic CRH; however, mechanisms by which they do so are not fully understood. The proximal promoter cAMP response element, negative glucocorticoid response element (nGRE), and methylated CpG islands all play a role in crh down-regulation. Dexamethasone (Dex)-repressed crh expression is associated with glucocorticoid receptor (GR) and histone deacetylase 1 (HDAC1) recruitment to the region of the crh promoter. Given that HDAC1 may be present in methylated CpG binding protein 2 (MeCP2) complexes, and that MeCP2 is known to play a role in regulating crh expression, we sought to determine whether or not HDAC1 and/or MeCP2 could interact with the GR. Dex enhanced GR interactions with both proteins. Glucocorticoid regulation of crh has also been associated with CpG methylation; thus we assessed whether GR could interact with a DNA methyltransferase (DnMT). Indeed, the GR interacted with DnMT3b, but not DnMT3a. In addition, Dex-induced occupancy of the crh promoter by HDAC1, MeCP2, and DnMT3b was associated with an increased level of promoter methylation, which appeared to be CpG site specific. Lastly, to extend previous assessment of chromatin modifications in this promoter region, the degree of histone methylation was measured. Dex increased trimethylation of histone 3-lysine 9, a marker of gene suppression; however, levels of di- and trimethylated histone 3-lysine 4, markers of gene activation, were not significantly changed. Taken together, the data suggest that Dex-mediated crh suppression involves formation of a repressor complex consisting of GR, MeCP2, and HDAC1, recruitment of DnMT3b, and associated changes in proximal promoter CpG methylation.
机译:糖皮质激素下调下丘脑CRH的表达;但是,他们这样做的机制还不完全清楚。近端启动子cAMP反应元件,糖皮质激素阴性反应元件(nGRE)和甲基化CpG岛均在crh下调中发挥作用。地塞米松(Dex)抑制的crh表达与糖皮质激素受体(GR)和组蛋白脱乙酰基酶1(HDAC1)募集到crh启动子区域有关。鉴于HDAC1可能存在于甲基化的CpG结合蛋白2(MeCP2)复合物中,并且已知MeCP2在调节crh表达中起作用,我们试图确定HDAC1和/或MeCP2是否可以与GR相互作用。 Dex增强了GR与这两种蛋白质的相互作用。 crh的糖皮质激素调节作用也与CpG甲基化有关。因此,我们评估了GR是否可以与DNA甲基转移酶(DnMT)相互作用。实际上,GR与DnMT3b交互,但与DnMT3a不交互。此外,Dex诱导的HDAC1,MeCP2和DnMT3b对crh启动子的占用与启动子甲基化水平的升高有关,这似乎是CpG位点特异性的。最后,为了扩展先前对该启动子区域中染色质修饰的评估,测量了组蛋白甲基化的程度。右旋糖增强了组蛋白3-赖氨酸9(一种基因抑制的标记)的三甲基化;然而,基因激活标记物二甲基化和三甲基化组蛋白3-赖氨酸4的水平没有明显改变。两者合计,数据表明,Dex介导的crh抑制涉及由GR,MeCP2和HDAC1组成的阻遏物复合物的形成,DnMT3b的募集以及近端启动子CpG甲基化的相关变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号